期刊文献+

玻璃体手术治疗眼内晚期视网膜母细胞瘤临床研究 被引量:9

Vitreous surgery for advanced intraocular retinoblastoma
在线阅读 下载PDF
导出
摘要 目的探讨玻璃体手术治疗眼内晚期视网膜母细胞瘤的效果。方法 2012年7月至2013年6月,选择眼内晚期(D期或E期)视网膜母细胞瘤患儿11例(12眼),采用博士伦23G玻璃体切割系统,进行玻璃体视网膜手术,包括玻璃体切割、肿瘤切除、视网膜光凝、眼内填充等。手术后随访6~18个月(平均9.4个月)。结果所有患眼均完成视网膜肿物切除。术后10眼视网膜裂孔封闭、视网膜复位;2眼因肿瘤范围大,视网膜大部分切除。8眼硅油填充,2眼行C3F8填充,2眼未作眼内填充。随访末,病情稳定者8眼,肿瘤复发4眼,眼球摘除1眼,因肿瘤眼外转移去世1例,2眼再行玻璃体内注射马法兰。硅油取出3眼,硅油置换1眼,4眼硅油长期填充。视力保持0.2以上5眼,患儿因年龄小不配合视力检查者7眼。并发白内障2眼,行白内障摘出术。结论玻璃体手术能够有效切除眼内晚期视网膜母细胞瘤,对保留眼球和患眼视力,提高患儿生存率有一定帮助,但其安全性和长期疗效还有待进一步研究。 Objective To investigate the effects of vitreous surgery for advanced intraocular retinoblastoma. Methods From July 2012 to June 2013,11 cases( 12 eyes) with advanced intraocular retinoblastoma( stage D or E) were collected. Vitreoretinal operation was performed using the Bausch & Lomb 23 G vitrectomy system, including vitrectomy, retinal tumor resection,photocoagulation and intraocular tamponade. After operation the follow-up time ranged from 6months to 18 months( averaged 9. 4 months). Results Retinal tumor resection was completed in all patients. Retinal holes were closed and retina reattached in10 eyes. The tumor was too large and more retinal excisions were made in 2 eyes. There were 8 eyes with silicone oil tamponade,2eyes with C3F8 tamponade and 2 eyes with no tamponade. At the end of follow-up,the disease was stable in 7 eyes,tumor recurred in 4 eyes,1 eye underwent enucleation and 1 case died from tumor extraocular metastasis. Three eyes underwent silicone oil removal,1 eyes underwent silicone oil replacement. Visual acuity remained above 0. 2 in 5 eyes,7 cases were too young to be able to check visual acuity. Complicated cataract occurred in 2 eyes,the cataract extractions were performed. Conclusion Vitreous operation can effectively remove advanced intraocular retinoblastoma,retain the eyeball and visual acuities, and help to improve the survival rate,but its safety and long-term efficacy need to further study.
出处 《眼科新进展》 CAS 北大核心 2014年第8期764-765,768,共3页 Recent Advances in Ophthalmology
基金 深圳市卫人委项目(编号:201302133)~~
关键词 视网膜母细胞瘤 玻璃体手术 激光光凝 retinoblastoma vitreous surgery laser photocoagulation
  • 相关文献

参考文献14

  • 1Chawla B, Khurana S, Sen S, Sharma S. Clinical misdiagnosis of retinoblastoma in Indian children [ J ]. Br J Ophthalmol, 2014,98 (4) :488-493.
  • 2Villegas VM, Hess D J, Wildner A, Gold AS, Murray TG. Retino- bl astoma [ J ]. Curt Opin Ophthalmol, 2013,24 ( 6 ) : 581-588.
  • 3韩非,蒋炜,张黔义,吴燕,胡峥,邱敏.视网膜母细胞瘤研究进展[J].西南军医,2006,8(3):63-64. 被引量:5
  • 4Lee V, Hungerford JL, Bunce C,Ahmed F, Kingston JE, Plowman PN. Globe conserving treatment of the only eye in bilateral reti- noblastoma[ J]. Br J Ophthalmo1,2003,87 ( 11 ) : 1374-1380.
  • 5Smith S J, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic re- view[ J]. Br J Ophthalmol,2013,98 ( 3 ) :292-297.
  • 6梁建宏,黎晓新,尹虹,姜燕荣,刘桂兰,张乐萍,王彬.视网膜母细胞瘤患者全身化学药物治疗联合眼部治疗的临床疗效观察[J].中华眼底病杂志,2007,23(5):332-335. 被引量:10
  • 7钱江,薛康,高怡谨,袁一飞,单海东,毕颖文.视网膜母细胞瘤化学减容加局部治疗的临床疗效分析[J].中华眼科杂志,2010,46(4):312-316. 被引量:13
  • 8Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard F, Dunkel I, et al. A proposal for an international retinoblastoma staging system [ J ]. Pediatr Blood Cancer,2006,47 ( 6 ) : 801-805.
  • 9Chantada GL, Doz F, Orjuela M, Qaddoumi I, Sitorus RS, Kepak T, et al. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group [ J ]. Pediatr Blood Cancer,2008,50 ( 3 ) : 692-694.
  • 10Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT ,Marls JM, et al. Chemoreduction in the initial management of intraocular retinoblastoma [ J ]. Arch Ophthalmol, 1996, 114 (11) :1330-1338.

二级参考文献39

  • 1李彬,孙宪丽.重视对视网膜母细胞瘤患儿的个体化综合治疗[J].中华眼科杂志,2007,43(6):481-483. 被引量:19
  • 2Ferris FL, Chew EY. A new era for the treatment of retinoblastoma. Arch Ophthalmol, 1996,114 : 1339-1343.
  • 3Murphree AL, ViUablanca JG, Deegan 3^rd WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol, 1996, 114 : 1348- 1356.
  • 4Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology, 2006,113:2276-2280.
  • 5Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with retinoblastoma. Ophthalmology, 1988, 95 : 1583-1587.
  • 6Shields CL, Mashayekhi A, Cater J, et al. Chemoreduction for retinoblastoma: Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol, 2004,138:329-337.
  • 7Shields CL, Shelil A, Cater J, et al. Development of new retinoblastomas following six cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol, 2003,121 : 1571-1576.
  • 8Schueler AO, Anastassiou G, Jurldies C, et al. De Novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma. Retina, 2006, 26: 425- 431.
  • 9Epstein J, Shields CL, Shields JA, et al. Trends in the management of retinohlastoma; Evaluation of 1196 consecutive eyes during 1974-2001. J Pediatr Ophthalmol Strab, 2003,40 : 196-203.
  • 10Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol. 1980. 98: 1204-1210.

共引文献31

同被引文献40

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部